−£24.73m
vs Dec 2023Active11614863Private limited companySaffron Walden
BIOCRUCIBLE LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
BIOCRUCIBLE LTD is an active private limited company (company number 11614863) incorporated on 10 October 2018, registered in Saffron Walden. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 31 December 2024, showing net assets of −£24.73m and cash of £92k, with 87 employees on average. Turnover was £923k and profit for the year −£8.61m. Net assets fell 53% on the prior period (−£16.12m).
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Key dates
- Incorporated
- 10 October 20188 yrs ago
- Next accounts due
- 30 September 202622 days overdue
- Confirmation statement due
- 24 October 2027in 367 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£92k
−92%vs Dec 2023£923k
+364%vs Dec 202387
+18%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£24.73m | £92k | — | £2.97m | £923k | −£8.61m | 87 |
| 31 December 2023 | −£16.12m | £1.12m | — | £6.14m | £199k | −£5.08m | 74 |
| 1 January 2023 | — | — | — | — | — | — | — |
Current ratio1.62Current assets ÷ creditors within one year
Net margin-932.7%Profit for the year ÷ turnover
Cash per employee£1,056Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Filing and accounts signals
- Net assets below zeroNet assets £-24,728,537 at 31 December 2024
- Net assets down 25% or more on the prior period-53.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.62
- Cash at bank of £50,000 or moreCash £91,865
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 10 October 2018
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
06
Ownership and control
No active person with significant control is registered.
- Mr Niall Antony Armes
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 367 days
- Next accounts due22 days overdue
- Accounts period endNet liabilities £24.73m · full accounts
- Accounts period endNet liabilities £16.12m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Cambridge
- VIANAUTIS BIO LIMITEDCambridge · inc. Oct 2018
- CAMBRIDGE ONCOLOGY LTDCambridge · inc. Nov 2018
- HEPAPRINT LTDCambridge · inc. Nov 2018
- INVITEQ POLYMER TECHNOLOGY LIMITEDCambridge · inc. Nov 2018
- CC BIOTECH LTD.Cambridge · inc. Aug 2018
- KALIUM HEALTH LTDCambridge · inc. Aug 2018
All companies incorporated on 10 October 2018 · in Oct 2018.
09
Reminders for BIOCRUCIBLE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.